DuPont to Acquire Donatelle Plastics

DuPont has signed an agreement to acquire US medical device contract manufacturer Donatelle Plastics. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. Financial details of the deal were not disclosed.

"Our healthcare strategy is focused on offering a comprehensive suite of solutions for customers in high-growth therapeutic areas," said Jon Kemp, president of DuPont Electronics & Industrial (E&I). "Donatelle Plastics Incorporated will be the second acquisition, following Spectrum last year, that will deepen our expertise in the medical device market segments and enhance our position as a partner of choice for our customers.”

DuPont’s healthcare exposure within the Industrial Solutions line of business of the E&I segment includes Spectrum, a producer of specialty plastics for medical device components, and Liveo, a provider of silicone solutions for healthcare applications. The acquisition of Donatelle Plastics will bring complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building.

According to DuPont, Donatelle Plastics has a strong financial growth profile aligned to attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.

Founded in 1967 and headquartered in New Brighton, Minnesota, Donatelle Plastics has a workforce of more than 400 employees and operates a facility strategically located in a medical technologies hub near leading original equipment manufacturers.

© Shannon Fagan/Getty Images
© Shannon Fagan/Getty Images

Company

DuPont Company

101.Beech St. 16-1216
19880 Wilmington

Company contact







Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.